BASF’s Restructuring Delivers Tangible Results

The ongoing transformation at German chemical giant BASF is gaining significant momentum, with recent corporate actions and financial updates demonstrating the concrete impact of its strategic overhaul.

Financial Targets Surpassed and Outlook Strengthened

The company’s cost-reduction initiative is progressing ahead of schedule. By the end of 2025, BASF achieved annualized savings of approximately €1.7 billion, exceeding its original target by €100 million. Management has now raised its savings goal for the end of 2026 to €2.3 billion, up from the initial €2.1 billion projection.

Reflecting this improved operational efficiency, BASF has also upgraded its financial forecast for 2026. The company anticipates EBITDA before special items to land between €6.2 billion and €7.0 billion. This positive momentum is mirrored in its share price, which reached a new 52-week high of €51.96. The stock has gained roughly 16% since the start of the year. Shareholders are expected to scrutinize the transformation’s progress closely at the Annual General Meeting scheduled for April 30.

Portfolio Streamlining Advances with Two Key Deals

Two specific announcements underscore the systematic approach to portfolio simplification. Firstly, BASF Agricultural Solutions has finalized the sale of its production facilities at the Höchst Industrial Park to ProChem InnoTec GmbH. These assets, previously used for manufacturing glufosinate-ammonium, had been available since production ceased at the end of 2024. ProChem InnoTec’s CEO, Jochen Pohl, called the acquisition of the permitted capacity exceeding 24,000 metric tons per year a “milestone” for his group. The purchase price was not disclosed by either party.

Should investors sell immediately? Or is it worth buying BASF?

Concurrently, the divestment of the coatings business is taking shape. Jens Luehring is slated to become the CEO of BASF Coatings following the completion of the transaction with private equity firm Carlyle and the Qatar Investment Authority. The €7.7 billion deal, agreed upon in October 2025, is expected to close in the second quarter of 2026. It should generate a pre-tax cash inflow of about €5.8 billion for BASF, which will retain a 40% minority stake in the unit.

Capital Allocation and Pricing Adjustments

Proceeds from these portfolio actions are being allocated strategically. Part of the fresh capital is funding a share buyback program of up to €1.5 billion, which is set to run until the end of June 2026.

Furthermore, in response to increased raw material, energy, and logistics costs, BASF is implementing significant price increases for its commodity amines portfolio in Europe. The hikes will reach up to 30%. These moves collectively highlight a company actively reshaping its business profile and strengthening its financial foundation.